<DOC>
	<DOCNO>NCT01270646</DOCNO>
	<brief_summary>Impact intraventricular electrical activation resynchronization therapy . We seek evaluate impact Cardiac Resynchronization Therapy ( CRT ) electrical activation Left Ventricle ( LV ) . The first goal study evaluate CRT able decrease heterogeneity LV activation heart failure patient . A second goal evaluate electrical determinant clinical response CRT use invasive non-invasive mapping technology .</brief_summary>
	<brief_title>Impact Intraventricular Electrical Activation Resynchronization Therapy</brief_title>
	<detailed_description>Comprehensive study , prospective , monocentric cohort study . Biventricular pace effective therapy improve end stage heart failure patient , however 30 % patient unresponsive therapy . Among others , optimization Left Ventricle ( LV ) pace site location critical optimize response Cardiac Resynchronization Therapy ( CRT ) . Whether good comprehension baseline LV electrical activation help determine optimal LV lead location remain investigate . After informed consent patient include sudy . Day 1 : CRT device implant general anesthesia conventional fashion . The coronary sinus lead implant guide acute hemodynamic response ( + ( dP/dt ) max ) use RADI guide wire . After device implantation , steerable mapping catheter insert LV cavity build tridimensional activation map LV . This map obtain without CRT . From maps different parameter describe LV activation measure compare patient without CRT . Quantitative parameter : Global LV activation time ( LVATG ) ( primary outcome ) ; septal activation time ( LVTAS ) ; Global intra-LV dispersion time Qualitative parameter : presence intraLV line block , area late activation . Day 5±2 : A non-invasive map LV record CardioInsight ® system without CRT . The parameter measure compare obtain invasive mapping . A 3 6 month follow-up visit include clinical , biological evaluation ( NYHA status , 6-min walk test , BNP ) patient perform additional transthoracic echocardiography 6 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Adult ( age 18 ) Sinus rhythm Patient must sign informed consent Cardiac insufficiency whatever cause ( ischemic nonischemic ) Patient eligible implantation ventricular resynchronization device patient ventricular resynchronization device procedure ventricular tachycardia ablation Left ventricular ejection fraction &lt; 35 % NYHA Class II IV optimal medical treatment Patient cover national healthcare insurance Pregnant woman Sequel transmural myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Cardiac insufficiency</keyword>
	<keyword>Invasive procedure</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Noninvasive procedure</keyword>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Mapping</keyword>
	<keyword>Cardiac resynchronisation therapy</keyword>
	<keyword>Open study</keyword>
	<keyword>Cardiac Pacings , Artificial</keyword>
	<keyword>Hemodynamics</keyword>
</DOC>